Page 206 - Haematologica Vol. 107 - September 2022
P. 206

ARTICLE - ITP antibody predicts desialylation and apoptosis S.S. Zheng et al.
44. Vollenberg R, Jouni R, Norris PAA, et al. Glycoprotein V is a rel- evant immune target in patients with immune thrombocytope- nia. Haematologica. 2019;104(6):1237-1243.
45. Porcelijn L, Schmidt DE, van der Schoot CE, Vidarsson G, de Haas M, Kapur R. Anti-glycoprotein IbĪ± autoantibodies do not impair circulating thrombopoietin levels in immune thrombo- cytopenia patients. Haematologica. 2020;105(4):e172-e174.
46. Yamamoto K, Kawasaki N. Chapter Eleven - Detection of Weak- Binding Sugar Activity Using Membrane-Based Carbohydrates. In: Fukuda M, ed. Methods in Enzymology: Academic Press. 2010:233-240.
47. Porcelijn L, Huiskes E, Oldert G, Schipperus M, Zwaginga JJ, de Haas M. Detection of platelet autoantibodies to identify im- mune thrombocytopenia: state of the art. Br J Haematol. 2018;182(3):423-426.
48. Grodzielski M, Goette NP, Glembotsky AC, et al. Multiple con-
comitant mechanisms contribute to low platelet count in pa-
tients with immune thrombocytopenia. Sci Rep. 2019;9(1):2208. 49. Amini SN, Porcelijn L, Sobels A, et al. Anti-glycoprotein anti-
bodies and sequestration pattern of indium labeled platelets in
immune thrombocytopenia. Blood Adv. 2022;6(6):1797-1803
50. Vrbensky JR, Moore JE, Arnold DM, Smith JW, Kelton JG, Nazy I.
The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta- analysis of a diagnostic test. J Thromb Haemost. 2019;17(5):787-794.
51. Arnold DM, Santoso S, Greinacher A. Platelet Immunology Scientific Subcommittee of the ISTH. Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia. J Thromb Haemost. 2012;10(4):695-697.
Haematologica | 107 September 2022
2205




















































































   204   205   206   207   208